封面
市场调查报告书
商品编码
1196846

胃肠病门诊手术中心市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Gastroenterology Ambulatory Surgery Center Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

胃肠病门诊手术中心市场预计在预测期内(2022 年至 2027 年)的复合年增长率为 7%。

COVID-19 大流行似乎对大流行期间的市场增长产生了负面影响。 这主要是由于世界各地突然关闭,导致劳动力和员工短缺,以及仅优先处理紧急情况,这对市场增长产生了负面影响。 例如,2020 年 4 月,医疗保险和医疗补助服务中心宣布,它将建议在与医学协会和协会的分阶段框架合作中推迟非必要的手术和其他程序。 因此,在 COVID-19 大流行期间强制取消或推迟择期手术等运营限制对市场增长产生了负面影响。 然而,在大流行后时期,这些严格的限制有所放鬆,患者的涌入逐渐增加,为市场参与者提供了有利可图的机会。

胃肠道疾病发病率增加等因素是促进市场增长的主要因素。 例如,2020 年发表在《肛门、直肠和结肠杂誌》上的一项调查表明,日本约有 18 万溃疡性结肠炎患者。 此外,在拉丁美洲,新兴工业化地区的发病率和患病率正在增加。 根据发表在 Therapeutic Advances in Gastroenterology Journal 2020 上的一项研究,拉丁美洲的溃疡性结肠炎 (UC) 发病率为 0.04-8.00/100,000,患病率为 0.23-76.1/100,000。我来了。 研究表明,各种胃肠道疾病的患病率不断上升,预计将推动市场增长。

此外,从医院转向门诊手术中心的偏好也有望推动市场增长。 例如,根据 Medicare Payments Advisory Board 和 VMG Health Data 于 2021 年 6 月发布的数据,在过去十年中,门诊手术中心的门诊手术量有所增加。 其他驱动因素包括胃肠道疾病的手术干预和住院治疗增加,以及生物製药公司对研发的投资增加。 例如,截至 2022 年 8 月,根据国家临床试验 (NCT) 註册处的数据,大约有 35,967 项正在进行的与胃肠道疾病相关的临床试验处于不同的发展阶段。 这些研究的积极结果可能会在预测期内为增加胃肠病门诊手术中心创造新的机会。

因此,由于上述因素,胃肠病门诊手术中心有望在预测期内实现增长。

胃肠病门诊手术中心市场趋势

在胃肠门诊手术中心市场,独立细分市场有望占据主要市场份额

预计在预测期内,自我维持的部分将主导市场增长。 独立拥有的部分主要由医生拥有的门诊手术中心组成,由于对临床环境和提供给患者的护理质量的最大专业控制,预计将占最大份额。 这使医生可以在一个环境中专注于少数程序。 门诊内窥镜检查服务中心是独立的设施,旨在执行低成本的胃肠道手术。 这种独立设施的有益特性增加了患者的需求,并使製造商能够实施各种营销策略以促进市场增长。 据报导,溃疡性结肠炎(UC)的发病率和患病率在新兴工业化地区正在增加。 根据 2020 年 7 月发表的题为“拉丁美洲溃疡性结肠炎流行病学和负担回顾”的研究报告,拉丁美洲溃疡性结肠炎 (UC) 的发病率在 0.04 到 8.00/100,000 之间。已发现患病率范围从 0.23 到 76.1/100,000。 因此,调查和研究表明溃疡性结肠炎的发病率和患病率有所增加,从而产生了对该细分市场的需求。

鑑于这些因素,该行业有望在预测期内实现增长。

预计北美将占据很大的市场份额,并且预计在预测期内也会如此。

由于美国胃肠道问题的高发率和门诊手术中心的广泛采用,预计美国将引领全球市场。 例如,根据美国国家糖尿病、消化和肾臟疾病研究所 (NIDDK) 于 2020 年发表的一项研究,美国每年有 60 至 7000 万人患有消化系统疾病。 此外,该地区门诊手术中心的强大存在也有助于市场增长。 例如,2020 年 Medicare Payments Advisory Board 发布的数据显示,美国有 9280 多家活跃的门诊手术中心。 此外,主要市场参与者的出现和产品开发的先进技术预计将使该地区占据主导地位。

同样,推出创新产品以满足日益增长的胃肠门诊手术中心服务需求。 例如,2020 年 1 月,宾得医疗获得美国食品和药物管理局 (FDA) 510(K) 批准的 Imagina 内窥镜系统,这是一种革命性的内窥镜平台,用于门诊手术中心的胃肠道 (GI) 程序。宣布已收购 此外,不断增加的研发活动和良好的医疗保健基础设施正在显着推动该地区的整体市场增长。

胃肠病门诊手术中心市场的竞争对手分析

胃肠病门诊手术中心市场分散且竞争激烈,由几家主要参与者组成。 从市场份额的角度来看,一些主要参与者主导着市场。 目前主导市场的一些公司是 Alpha Surgery Centers, LLC, Becton, Dixon and Company, Hill-Rom Holdings, GE Healthcare, Koninklijke Phillips NV, Cook Medical, Medtronic, Stomach Health LLC, Ohio Gastroenterology. Group Inc., Ontario高级外科中心、全民健康服务公司等。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 消化系统疾病增加
    • 越来越偏爱门诊服务
  • 市场製约因素
    • 监管不确定性
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分(基于价值的市场规模:100 万美元)

  • 按服务
    • 诊断服务
    • 外科服务
  • 由所有者
    • 医院系统
    • 独立
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Alfa Surgery Center, LLC
    • Becton, Dickison and company
    • Hill-Rom Holdings
    • GE healthacre
    • Koninklijke PhilipsN.V
    • Medtronic
    • Gastro Health LLC
    • Ohio Gastroeneterology Group Inc
    • Ontario Advanced Surgery Center
    • Universal Health Services Inc

第7章 市场机会今后动向

简介目录
Product Code: 90546

The Gastroenterology Ambulatory Surgery Center Market is projected to register a CAGR of 7% during the forecast period (2022-2027).

The COVID-19 pandemic seemed to negatively impact the market's growth during the pandemic period. This factor is mainly due to the sudden imposition of lockdowns across the globe, which resulted in a lack of workforce & staff-also, prioritizing only the emergency cases negatively impacted the market's growth. For instance, in April 2020, the Centers for Medicare & Medicaid Services announced recommendations for postponing non-essential surgeries and other procedures with the help of a tiered framework collaboration with medical societies and associations. Thus, operational restrictions such as mandates to stop or postpone elective surgeries during the COVID-19 pandemic negatively impacted the market's growth. However, the relaxations of such strict restrictions during the post-pandemic period provided lucrative opportunities for the market players as the patient influx will increase gradually.

The factors such as growing incidences of gastrointestinal disorders are the major factors contributing to the market's growth. For instance, a research study published in the Journal of Anus, Rectum, and Colon in 2020 showed around 180,000 patients with ulcerative colitis in Japan. In addition, the incidence and prevalence in Latin America have been rising in newly industrialized regions. According to a research study published in Therapeutic Advances in Gastroenterology Journal 2020, the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively. Research studies showing the increasing prevalence of various gastrointestinal disorders are expected to drive the market's growth.

Moreover, shifting preference toward ambulatory surgical centers from hospitals is also expected to boost the market's growth. For instance, according to the Medicare Payment Advisory Commission and VMG Health Data published in June 2021, the outpatient surgical volume in ambulatory surgical centers has increased over the last decade. Other driving factors include the rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies. For instance, as of August 2022, there were around 35967 ongoing clinical trials related to gastrointestinal diseases across different phases of development, as per the National Clinical Trial (NCT) registry. The positive outcomes from these studies can create new opportunities for an increase in gastroenterology ambulatory surgery center over the forecast period.

Thus, due to the abovementioned factors, the gastroenterology ambulatory surgical center is expected to grow during the forecast period.

Gastroenterology Ambulatory Surgery Center Market Trends

The Freestanding Segment is Expected to Hold a Major Market Share in the Gastroenterology Ambulatory Surgery Center Market

The freestanding segment is expected to hold a dominating share in the growth of the market during the forecast period. The freestanding ownership segment, which mainly comprises physician-owned ambulatory surgery centers, is expected to account for the maximum share owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows the physicians to focus on a small number of procedures in a single setting. Endoscopic Ambulatory Service Centers are freestanding facilities designed to carry out gastrointestinal procedures at a low cost. Such beneficial characteristics of the freestanding ownership segment led to the increasing demand for the same among the patients, which allowed the manufacturers to implement various market strategies for market growth. In addition, the incidence and prevalence of ulcerative colitis (UC) have been reported to be rising in newly industrialized regions. According to a research study published in July 2020 titled 'Review of the Epidemiology and Burden of Ulcerative Colitis in Latin America', the incidence and prevalence of ulcerative colitis (UC) in Latin America were between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000. Therefore, the research and studies show the increasing incidence and prevalence of the Ulcerative Colitis condition, and this is generating demand for the segment.

Thus due to these factors, the studied segment is expected to grow during the forecast period.

North America is Expected to Hold a Significant Share in the Market and is expected to do the Same in the Forecast Period.

The United States is expected to command the global market due to the high incidence of Gastroenterology problems and the high adoption rate of ambulatory surgical centers. For instance, According to the study published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 2020, 60 to 70 million people suffer from gastrointestinal diseases every year in the United States. Additionally, the strong presence of ambulatory surgical centers in the region contributes to the market's growth. For instance, according to the data published by the Medicare Payment Advisory Commission in 2020, the number of active ambulatory surgical centers in the United States is more than 9,280. Moreover, the presence of major market players and advanced technologies for product development is expected to mark this region with dominating share.

Similarly, the innovative product launches to meet the growing demand for gastroenterology ambulatory surgical center services. For instance, in January 2020, Pentax Medical announced that it had received United States Food and Administration (FDA) 510 (K) clearance for its Imagina Endoscopy System, an innovative endoscopy platform for gastrointestinal (GI) procedures at ambulatory surgery centers. Additionally, an increase in research and development activities and favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Gastroenterology Ambulatory Surgery Center Market Competitor Analysis

The Gastroenterology Ambulatory Surgery Center Market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some of the companies which are currently dominating the market are Alfa Surgery Center, LLC, Becton, Dickison and Company, Hill- Rom Holdings, GE Healthcare, Koninklijke Philips N.V, Cook Medical, Medtronic, Gastro Health LLC, Ohio Gastroenterology Group Inc, Ontario Advanced Surgery Center, Universal Health Services Inc., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing incidences of gastrointestinal diorders
    • 4.2.2 Rising preferences for ambulatory services
  • 4.3 Market Restraints
    • 4.3.1 Regulatory uncertainaties
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Services
    • 5.1.1 Diagnostic Services
    • 5.1.2 Surgical Services
  • 5.2 By Ownership
    • 5.2.1 Hospital-Affiliated
    • 5.2.2 Freestanding
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alfa Surgery Center, LLC
    • 6.1.2 Becton, Dickison and company
    • 6.1.3 Hill-Rom Holdings
    • 6.1.4 GE healthacre
    • 6.1.5 Koninklijke PhilipsN.V
    • 6.1.6 Medtronic
    • 6.1.7 Gastro Health LLC
    • 6.1.8 Ohio Gastroeneterology Group Inc
    • 6.1.9 Ontario Advanced Surgery Center
    • 6.1.10 Universal Health Services Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS